PTGIR and chronic obstructive pulmonary disease: Given that the findings of the PERFECT trial have not yet been published, more studies are needed to assess the role of PGI2 in COPD-associated PH and the efficacy of PGI2 analogues and PGI2 receptor agonists use to treat patients with PH due to COPD.